Background illustration for clinical trials search

Paid Clinical Trials Greensboro

Discover 1,825 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Olfactory Biopsies

for
Alzheimer Disease, Smell Loss, Smell Dysfunction
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT07021040

Recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

for
Multiple Myeloma
Location: Chapel Hill NC, Wilson NC, Chattanooga TN, Canton OH,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05714839

Phase 1, Phase 2, Recruiting

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

for
Stroke
Location: Durham NC, Baltimore MD, Cincinnati OH, Louisville KY,
Sponsor: State University of New York at Buffalo

Sex: All

Age: 18+

Code: NCT00682695

Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Durham NC, Cary NC, Raleigh NC, Boiling Springs SC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT06900595

Phase 2, Recruiting

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Durham NC, Cincinnati OH, Cleveland OH, New York NY,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06859762

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Location: Durham NC, Myrtle Beach SC, Charleston SC,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07190300

Phase 1, Phase 2, Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Durham NC, Washington D.C. DC, Baltimore MD, Atlanta GA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase 1, Phase 2, Recruiting

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

for
Type 1 Diabetes Mellitus
Location: Chapel Hill NC, Charlottesville VA, Asheville NC,
Sponsor: Sanofi

Sex: All

Age: 1 - 25

Code: NCT07088068

Phase 3, Recruiting

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

for
Heart Failure - NYHA II - IV
Location: Durham NC, Charlotte NC, Charlottesville VA,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07069738

Recruiting

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

for
BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain,
Location: Durham NC, Washington D.C. DC, Baltimore MD,
Sponsor: University of California, San Francisco

Sex: All

Age: 1 - 25

Code: NCT07110246

Phase 2, Recruiting

Prescription of Letrozole for Uterine Myoma

for
Leiomyoma, Uterine, Leiomyoma, Fibroid, Fibroid Uterus
Location: Durham NC, Jackson MS, Rochester MN, Los Angeles CA,
Sponsor: University of California, San Francisco

Sex: Female

Age: 21 - 53

Code: NCT06143631

Recruiting

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

for
Breast Cancer, Metastatic
Location: Durham NC, Fairfax VA, Washington D.C. DC, Canton OH,
Sponsor: ALX Oncology Inc.

Sex: All

Age: 18+

Code: NCT07007559

Phase 2, Recruiting

Enhancing Heart Allograft Function With the OCS Heart System Trial

for
Heart Transplant
Location: Durham NC, New York NY, Valhalla NY, Tampa FL,
Sponsor: TransMedics

Sex: All

Age: 18+

Code: NCT07145515

Recruiting

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

for
Advanced Hepatocellular Carcinoma,
Location: Durham NC, Raleigh NC, Fairfax VA, Falls Church VA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07166406

Phase 3, Recruiting

IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Durham NC, Washington D.C. DC, Baltimore MD,
Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07104032

Phase 3, Recruiting

Duke Customized Aortic Aneurysm Repair With Endovascular Stent-grafts - Duke CARES Trial

for
Aortic Disorders
Location: Durham NC
Sponsor: Chandler Long, MD

Sex: All

Age: 18+

Code: NCT07064460

Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for
Renal Cell Carcinoma (RCC),
Location: Durham NC, Charlottesville VA, Myrtle Beach SC,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05176483

Phase 1, Recruiting

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

for
Sickle Cell Disease
Location: Durham NC, Greenville NC, Greer SC, Clinton SC,
Sponsor: Pfizer

Sex: All

Age: 12+

Code: NCT05431088

Phase 2, Phase 3, Recruiting

129 Xenon Imaging in Patients Treated With Sotatercept

for
Pulmonary Hypertension, Pulmonary Arterial Hypertension
Location: Durham NC
Sponsor: Bastiaan Driehuys

Sex: All

Age: 18 - 70+

Code: NCT06351345

Phase 2, Recruiting

A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

for
Adenovirus Infections
Location: Durham NC, Washington D.C. DC, Atlanta GA,
Sponsor: SymBio Pharmaceuticals

Sex: All

Age: 0+

Code: NCT07387367

Phase 3, Recruiting